Rockwell Medical (RMTI) Cash from Financing Activities (2010 - 2026)

Rockwell Medical (RMTI) has 17 years of Cash from Financing Activities data on file, last reported at -$813000.0 in Q1 2026.

• Quarterly Cash from Financing Activities fell 3.83% year-over-year to -$813000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 33.9% YoY) and the FY2025 annual result came in at $4.3 million, down 42.13% from the prior year.
• Cash from Financing Activities advanced to -$813000.0 in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $26.8 million in Q2 2022 to a low of -$6.0 million in Q4 2022.
• A 5-year average of $2.3 million and a median of -$631000.0 in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 447150.0% — and 2025, when it sank 539.89%.
• Tracing RMTI's Cash from Financing Activities over 5 years: stood at -$6.0 million in 2022, then surged by 87.6% to -$742000.0 in 2023, then jumped by 476.28% to $2.8 million in 2024, then tumbled by 137.93% to -$1.1 million in 2025, then gained by 23.23% to -$813000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$813000.0 (Q1 2026), -$1.1 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.